
Wanted: More Data, the Dirtier the Better
The computational immunologist Purvesh Khatri embraces messy data as a way to capture the messiness of disease. As a result, he’s making elusive genomic discoveries

Wanted: More Data, the Dirtier the Better
The computational immunologist Purvesh Khatri embraces messy data as a way to capture the messiness of disease. As a result, he’s making elusive genomic discoveries

Bacterially Boosted Mosquitoes Could Vex Viruses
Mosquitoes infected with Wolbachia bacteria are unable to transmit viruses to humans—and could curb the spread of viral disease. Karen Hopkin reports.


New Approach to Amputation Could Reduce Phantom Pain
The technique, tested in rodents, could yield better sensation and control of prosthetic limbs

The Gestation Equation: Testing Babies' Genes
Journalist Bonnie Rochman talks about her new Scientific American/Farrar, Straus and Giroux book, The Gene Machine: How Genetic Technologies Are Changing the Way We Have Kids—and the Kids We Have.

Resurrected: A Controversial Trial to Bring the Dead Back to Life
Scientists remain skeptical about an experimental approach to reverse brain death

Menstrual Cycle “on a Chip” Offers a New Window into Female Physiology
Researchers have completed the first laboratory model of the human female reproductive cycle

Detecting Radiation Exposure with a Blood Test
An RNA-based assay recently shown to work in monkeys could help triage victims of nuclear disasters

Trials of Embryonic Stem Cells to Launch in China
Studies to treat vision loss and Parkinson's disease are the first to proceed under new regulations

Fitness Bands Fail on Calorie Counts
Activity trackers accurately reckon heart rate—but they're way off in estimates of energy expenditure. Christopher Intagliata reports.

FDA Clears First Cancer Drug Based on Genetics of Disease, Not Tumor Location
Diseases with these traits occur throughout the body

Lab-Grown Blood Stem Cells Produced at Last
Two research teams cook up recipe to make long-sought cells in mice and people

Scientists Dismayed as Texas Leans into Unproved Stem Cell Treatments
Three bills under consideration in the state would make it easier to try unapproved therapies